. Results of gene-based tests on mutational load derived from the sequence kernel association optimal (SKAT-O) test. Shown here are the number of minor allele counts, and individual results for each of the three discovery collections (Hong Kong, Japan, and Singapore), as well as an overall meta-analysis p-value. Only Genes with P SKATO-meta < 1 x 10 -4 are shown.
# cases and # controls denote the number of minor allele counts in aggregate for all non-synonymous SNPs with individual minor allele frequency <0.05. Supplementary Table 15 . Study power as a function of minor allele frequency and odds ratio for genetic markers A) surpassing P < 1 x 10 -4 in the discovery collection of 2,119 exudative AMD cases and 5,691 controls so that they could be brought forward for further testing in the replication stage and B) surpassing P < 5 x 10 -8 in the combined meta-analysis of 6,345 exudative AMD cases and 15,980 controls. Conditions yielding ≥80% power are shaded in light blue. 
Singapore

Guangdong, China
Cases: All study subjects were Southern Han Chinese of Guangdong descent recruited at the Zhongshan Ophthalmic Center and Joint Shantou International Eye Center. Cases with exudative AMD underwent similar ocular examination as for the discovery collection in Hong Kong. The same recruitment criteria and were applied as for the discovery collection. 
Population-based Cohorts for Analysis of the Association between D442G and HDL
Singapore Chinese Eye Study
The SCES is a population-based cross-sectional study of eye diseases in Chinese adults 40 years of age or older residing in Singapore as described in the Singapore Discovery Cohort section. The methodology of the SCES study has been described in detail elsewhere. 12 Between 2009 and 2011, 3 Canon, Tokyo, Japan) was used to capture color photographs of retina of each eye after pupil dilation. AMD was graded based on retinal photos following the Wisconsin Age-Related Maculopathy Grading System. 13 Venous blood was collected and stored for DNA extraction. All participants had an interview (smoking status, use of lipid-lowering medication, etc.), systemic examination, and laboratory investigations using standard laboratory techniques, including measurements of serum lipid profiles. Genome-wide genotyping was done on 2,504 subjects using Illumina Human610-Quad (N =1889) or HumanOmniExpress (N = 615) BeadChips as described previously, followed by strict genotype quality controls. 16
Singapore Prospective Study Program
Samples of Singapore Prospective Study Program (SP2) were from a revisit of 4 previously conducted population-based surveys carried out in Singapore, including the Thyroid and Heart Study1982-1984, 17 the National Health Survey 1992, 18 the National University of Singapore Heart Study 1993-1995, 19 and the National Health Survey 1998. 20 These studies comprise random samplings of individuals from the Singapore population aged 24 to 95 years, with disproportionate sampling stratified by ethnicity to ensure sufficient sample size in minority ethnic groups. The details of study design, subject recruitments and clinical protocols were described previously. 21, 22 In brief, 5,157 subjects attended a comprehensive clinic examination at the Singapore Eye Research Institute that included systemic and ocular examination, retinal photography, and laboratory investigations. Venous blood samples were analyzed for lipid profiles at the National University Hospital Reference Laboratory for using an automated autoanalyzer (ADVIA 2400; Bayer Diagnostics, New York).
The genotyping for SP2 involved individuals of Chinese descent only. 23 Of the 2,867 blood-derived DNA samples, 392 samples were genotyped on the HumanHap 550v3, 1,459 samples on the 610-Quad, 817 samples on the 1M-Duov3, 191 samples on both 550v3 and 1M-Duov3, and 8 samples on both 610-Quad and 1M-Duov3. For the samples that were genotyped on two platforms, we used the genotypes from the denser platform in our study.
Nagahama Prospective Genome Cohort for the Comprehensive Human Bioscience
The Nagahama Prospective Genome Cohort for the Comprehensive Human Bioscience (the Nagahama Study) is a community-based prospective cohort study that aims to determine the prevalence and risk factors of various diseases in a community. The details of study design and methodology have been described elsewhere. 24 In brief, residents of Nagahama City who satisfied the following criteria were recruited as participants and were examined between November 2008 and November 2010: 1) age ≥30 and ≤74 years; 2) ability to participate on one's own; 3) no significant problems communicating in Japanese; 4) no current serious diseases/symptoms or health issues; and 5) voluntarily decided to participate in this study. A total of 9,804 Japanese individuals participated in the Nagahama Study. All participants underwent fundus photography using a digital retinal camera (CR-DG10; Canon, Tokyo, Japan) in a dark room. 24 The fundus photos were graded for the individuals aged ≥50 years (N = 6,118)
according to the simplified severity scale for AMD in the AREDS Study. 25 Information on smoking status and anti-lipid medication and was obtained via a self-reported questionnaire.
Smoking status was converted to Brinkman index.
Genomic DNA was extracted from peripheral blood samples by phenol-chloroform method. Of the participants, 3,712 individuals were genome-scanned using HumanHap610K
Quad Arrays, HumanOmni2.5M Arrays, and/or HumanExome Arrays (Illumina Inc., San Diego, California, USA). After our standard quality control, genomic imputation was performed on 192 participants' data that had been genotyped by every platform. Finally, the data that consists of 1,756,611 SNPs of 3,248 individuals were fixed. All study procedures were approved by the ethics committee of Kyoto University Graduate School of Medicine.
Coronary Heart Disease Case-Controls Collection in Singapore
The 
